{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:03:52Z","timestamp":1794866632235,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP 1066865"],"award-info":[{"award-number":["OPP 1066865"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Prevention and treatment of malaria during pregnancy is crucial in dealing with maternal mortality and adverse fetal outcomes. The World Health Organization recommendation to treat all pregnant women with sulfadoxine-pyrimethamine (SP) through antenatal care structures was implemented in Kenya in the year 1998, but concerns about its effectiveness in preventing malaria in pregnancy has arisen due to the spread of SP resistant parasites. This study aimed to determine the prevalence of SP resistance markers in\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      parasites isolated from pregnant women seeking antenatal care at Msambweni County Referral Hospital, located in coastal Kenya, between the year 2013 and 2015.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This hospital-based study included 106 malaria positive whole blood samples for analysis of SP resistance markers within the\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      gene (codons 51, 59 and 108) and\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      gene (codons 437 and 540). The venous blood collected from all pregnant women was tested for malaria via light microscopy, then the malaria positive samples were separated into plasma and red cells and stored in a \u2212\u00a086\u00b0 freezer for further studies. Archived red blood cells were processed for molecular characterization of SP resistance markers within the\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      and\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      genes using real time PCR platform and Sanger sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All samples had at least one mutation in the genes associated with drug resistance; polymorphism prevalence of\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      51\n                      <jats:bold>I<\/jats:bold>\n                      , 59\n                      <jats:bold>R<\/jats:bold>\n                      and 108\n                      <jats:bold>N<\/jats:bold>\n                      was at 88.7%, 78.3% and 93.4%, respectively, while\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      polymorphism accounted for 94.3% and 91.5% at 437\n                      <jats:bold>G<\/jats:bold>\n                      and 540\n                      <jats:bold>E<\/jats:bold>\n                      , respectively. Quintuple mutations (at all the five codons) conferring total SP resistance had the highest prevalence of 85.8%. Quadruple mutations were observed at a frequency of 10.4%, and 24.5% had a mixed outcome of both wildtype and mutant genotypes in the genes of interest.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The data suggest a high prevalence of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      genetic variations conferring resistance to SP among pregnant women, which may explain reduced efficacy of IPTp treatment in Kenya. There is need for extensive SP resistance profiling in Kenya to inform IPTp drug choices for successful malaria prevention during pregnancy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03263-z","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:02:40Z","timestamp":1590307360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2709-2569","authenticated-orcid":false,"given":"Stella Wanjiku","family":"Gikunju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Agola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael Omusebe","family":"Ondondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Kinyua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelle Desiree","family":"LaBeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Thiong\u2019o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Mutuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"key":"3263_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.3390\/tropicalmed3010018","volume":"3","author":"S Yaya","year":"2018","unstructured":"Yaya S, Uthman O, Amouzou A, Bishwajit G, Yaya S, Uthman OA, et al. Use of intermittent preventive treatment among pregnant women in sub-Saharan Africa: evidence from malaria indicator surveys. Trop Med Infect Dis. 2018;3:e18.","journal-title":"Trop Med Infect Dis"},{"key":"3263_CR2","unstructured":"WHO. World Malaria Report 2018. Geneva, World Health Organization, 2018."},{"key":"3263_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323\u201333.","journal-title":"Clin Infect Dis"},{"key":"3263_CR4","doi-asserted-by":"crossref","unstructured":"WHO. Lives at risk: malaria in pregnancy. Geneva, World Health Organization, 2013.","DOI":"10.1093\/law:epil\/9780199231690\/e575"},{"key":"3263_CR5","first-page":"165","volume":"2016","author":"National Malaria Control Programme, Kenya National Bureau of, Statistics. Malaria Indicator Survey","year":"2015","unstructured":"National Malaria Control Programme, Kenya National Bureau of, Statistics. Malaria Indicator Survey. Nairobi. Kenya. 2015;2016:165.","journal-title":"Kenya"},{"key":"3263_CR6","unstructured":"Bloland PB. Drug resistance in malaria. A Background Document for the WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, World Health Organization, 2001;12."},{"key":"3263_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12936-015-0909-7","volume":"14","author":"V Braun","year":"2015","unstructured":"Braun V, Rempis E, Schnack A, Decker S, Rubaihayo J, Tumwesigye NM, et al. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda. Malar J. 2015;14:372.","journal-title":"Malar J"},{"key":"3263_CR8","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1128\/AAC.00507-15","volume":"59","author":"AK Mbonye","year":"2015","unstructured":"Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, et al. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda. Antimicrob Agents Chemother. 2015;59:5475\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"3263_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12936-016-1387-2","volume":"15","author":"RA Kavishe","year":"2016","unstructured":"Kavishe RA, Kaaya RD, Nag S, Krogsgaard C, Notland JG, Kavishe AA, et al. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania. Malar J. 2016;15:335.","journal-title":"Malar J"},{"key":"3263_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1475-2875-11-134","volume":"11","author":"NC Iriemenam","year":"2012","unstructured":"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11:134.","journal-title":"Malar J"},{"key":"3263_CR11","unstructured":"WHO. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy. Geneva, World Health Organization, 2013."},{"key":"3263_CR12","unstructured":"County Government of Kwale. First county integrated development plan 2013: towards a globally competitive and prosperous nation. Kenya, 2013."},{"key":"3263_CR13","doi-asserted-by":"publisher","first-page":"e0007172","DOI":"10.1371\/journal.pntd.0007172","volume":"13","author":"ND McKittrick","year":"2019","unstructured":"McKittrick ND, Malhotra IJ, Vu DM, Boothroyd DB, Lee J, Krystosik AR, et al. Parasitic infections during pregnancy need not affect infant antibody responses to early vaccination against Streptococcus pneumoniae, diphtheria, or Haemophilus influenzae type B. PLoS Negl Trop Dis. 2019;13:e0007172.","journal-title":"PLoS Negl Trop Dis"},{"key":"3263_CR14","unstructured":"WHO. Microscopy examination of thick and thin blood films for identification of malaria parasites. Geneva, World Health Organization, 2016."},{"key":"3263_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1128\/JCM.02257-15","volume":"54","author":"J Liu","year":"2016","unstructured":"Liu J, Ochieng C, Wiersma S, Str\u00f6her U, Towner JS, Whitmer S, et al. Development of a TaqMan array card for acute-febrile-illness outbreak investigation and surveillance of emerging pathogens, including Ebola virus. J Clin Microbiol. 2016;54:49\u201358.","journal-title":"J Clin Microbiol"},{"key":"3263_CR16","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1128\/AAC.48.8.2924-2929.2004","volume":"48","author":"AP Alker","year":"2004","unstructured":"Alker AP, Mwapasa V, Meshnick SR. Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2004;48:2924\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"3263_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"3263_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12936-016-1638-2","volume":"15","author":"S Githinji","year":"2016","unstructured":"Githinji S, Noor AM, Malinga J, Macharia PM, Kiptui R, Omar A, et al. A national health facility survey of malaria infection among febrile patients in Kenya. Malar J. 2016;15:591.","journal-title":"Malar J"},{"key":"3263_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12936-016-1441-0","volume":"15","author":"RA Willilo","year":"2016","unstructured":"Willilo RA, Molteni F, Mandike R, Mugalura FE, Mutafungwa A, Thadeo A, et al. Pregnant women and infants as sentinel populations to monitor prevalence of malaria: results of pilot study in Lake Zone of Tanzania. Malar J. 2016;15:392.","journal-title":"Malar J"},{"key":"3263_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1475-2875-12-46","volume":"12","author":"FM Mutuku","year":"2013","unstructured":"Mutuku FM, Khambira M, Bisanzio D, Mungai P, Mwanzo I, Muchiri EM, et al. Physical condition and maintenance of mosquito bed nets in Kwale County, coastal Kenya. Malar J. 2013;12:46.","journal-title":"Malar J"},{"key":"3263_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.24321\/2455.7048.201904","volume":"4","author":"WK Mutwiri","year":"2019","unstructured":"Mutwiri WK. Status of Plasmodium falciparum resistance to sulfadoxine pyrimethamine in Kwale County Kenya. Epidemiol Int. 2019;4:20\u20135.","journal-title":"Epidemiol Int"},{"key":"3263_CR22","first-page":"9694372","volume":"2016","author":"JM Ndong Ngomo","year":"2016","unstructured":"Ndong Ngomo JM, Mawili Mboumba DP, M\u2019Bondoukwe NP, Niki\u00e9ma Ndong Ella R, BouyouAkotet MK. Increased prevalence of mutant allele Pfdhps 437G and Pfdhfr triple mutation in Plasmodium falciparum isolates from a rural area of Gabon, three years after the change of malaria treatment policy. Malar Res Treat. 2016;2016:9694372.","journal-title":"Malar Res Treat."},{"key":"3263_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12936-017-2160-x","volume":"17","author":"E Ruh","year":"2018","unstructured":"Ruh E, Bateko JP, Imir T, Taylan-Ozkan A. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo. Malar J. 2018;17:17.","journal-title":"Malar J"},{"key":"3263_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12936-019-2734-x","volume":"18","author":"T Jiang","year":"2019","unstructured":"Jiang T, Chen J, Fu H, Wu K, Yao Y, Urbano J, et al. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Malar J. 2019;18:101.","journal-title":"Malar J"},{"key":"3263_CR25","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/jac\/dkv160","volume":"70","author":"P Chauvin","year":"2015","unstructured":"Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in pregnant women in Yaound\u00e9 Cameroon: emergence of highly resistant pfdhfr\/pfdhps alleles. J Antimicrob Chemother. 2015;70:2566\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"3263_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4269\/ajtmh.17-0763","volume":"98","author":"E Hemming-Schroeder","year":"2018","unstructured":"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tom\u00e1s-Domingo P, Zhou G, et al. Impacts of antimalarial drugs on Plasmodium falciparum drug resistance markers, Western Kenya, 2003\u20132015. Am J Trop Med Hyg. 2018;98:692\u20139.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03263-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T19:12:59Z","timestamp":1621797179000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03263-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3263"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03263-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17951\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from each study participant before study participation. The ethical approvals were granted by the Kenyatta National Hospital Ethical Review committee; #P85\/03\/2013, the Institutional Review Board for Human Studies at University of Cleveland Case Medical Center; #01-13-13 and the KEMRI Scientific Ethics and Review Committee (SERU); #SSC3134.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}